Search Results - "Forman, Lisa M."

Reply: Living donor liver transplantation for people with PSC by Forman, Lisa M, Sapisochin, Gonzalo, Assis, David N, Arrivé, Lionel, Bergquist, Annika, Bowlus, Christopher L, Deneau, Mark, Ilyas, Sumera I, Lunsford, Keri E, Martinez, Mercedes, Shroff, Rachna, Tabibian, James H

Get full text

The association between hepatitis C infection and survival after orthotopic liver transplantation by Forman, Lisa M., Lewis, James D., Berlin, Jesse A., Feldman, Harold I., Lucey, Michael R.

“…The effect of hepatitis C viral (HCV) infection on patient and allograft survival after orthotopic liver transplantation is controversial. Hepatitis C…”
Get full text

Survival following liver transplantation from non-heart-beating donors by ABT, Peter L, DESAI, Niraj M, CRAWFORD, Michael D, FORMAN, Lisa M, MARKMANN, Joseph W, OLTHOFF, Kim M, MARKMANN, James F

“…To determine whether patient and graft survival following transplantation with non-heart-beating donor (NHBD) hepatic allografts is equivalent to…”
Get full text

Marked variation in disease acuity and outcomes on the liver transplant waiting list by sociodemographic characteristics by Jackson, Whitney E, Lopez, Rocio, Forman, Lisa M, Arrigain, Susana, Schold, Jesse D

“…Understanding the association of social determinants of health (SDOH) with liver transplant listing and wait list outcomes can inform healthcare policy and…”
Get full text

Long-Term Obeticholic Acid Therapy Improves Histological Endpoints in Patients With Primary Biliary Cholangitis by Bowlus, Christopher L., Pockros, Paul J., Kremer, Andreas E., Parés, Albert, Forman, Lisa M., Drenth, Joost P.H., Ryder, Stephen D., Terracciano, Luigi, Jin, Yuying, Liberman, Alexander, Pencek, Richard, Iloeje, Uche, MacConell, Leigh, Bedossa, Pierre

“…Primary biliary cholangitis (PBC) is an autoimmune disease characterized by bile duct destruction that can progress to cirrhosis. A liver biopsy substudy was…”
Get full text

Socioeconomic deprivation is associated with worse patient and graft survival following adult liver transplantation by Forman, Lisa M, Jackson, Whitney E, Arrigain, Susana, Lopez, Rocio, Schold, Jesse D

“…The impact of social determinants of health on adult liver transplant recipient outcomes is not clear at a national level. Further understanding of the impact…”
Get full text

Pro: Steroids Can Be Withdrawn After Transplant in Recipients With Autoimmune Hepatitis by Kalra, Avash, Burton, James R., Forman, Lisa M.

“…Corticosteroids have been a mainstay of immunosuppression following liver transplantation. However, evolution in the field of transplant immunology has…”
Get full text

Statins Show Promise Against Progression of Liver Disease by Francis, Prashanth, Forman, Lisa M.

“…Content available: Audio Recording Answer questions and earn CME…”
Get full text

Hepatitis C virus–infected women have a higher risk of advanced fibrosis and graft loss after liver transplantation than men by Lai, Jennifer C., Verna, Elizabeth C., Brown, Robert S., O'Leary, Jacqueline G., Trotter, James F., Forman, Lisa M., Duman, Jeffrey D., Foster, Richard G., Stravitz, R. Todd, Terrault, Norah A.

“…In natural history studies of hepatitis C virus (HCV) infection, women have a lower risk of disease progression to cirrhosis. Whether female sex influences…”
Get full text

Safety, tolerability, and efficacy of maralixibat in adults with primary sclerosing cholangitis: Open-label pilot study by Bowlus, Christopher L, Eksteen, Bertus, Cheung, Angela C, Thorburn, Douglas, Moylan, Cynthia A, Pockros, Paul J, Forman, Lisa M, Dorenbaum, Alejandro, Hirschfield, Gideon M, Kennedy, Ciara, Jaecklin, Thomas, McKibben, Andrew, Chien, Elaine, Baek, Marshall, Vig, Pamela, Levy, Cynthia

“…Primary sclerosing cholangitis (PSC) is frequently associated with pruritus, which significantly impairs quality of life. Maralixibat is a selective ileal bile…”
Get full text

Risk of advanced fibrosis with grafts from hepatitis C antibody–positive donors: A multicenter cohort study by Lai, Jennifer C., O'Leary, Jacqueline G., Trotter, James F., Verna, Elizabeth C., Brown, Robert S., Stravitz, R. Todd, Duman, Jeffrey D., Forman, Lisa M., Terrault, Norah A.

“…Over the last decade, the use of liver grafts from hepatitis C virus antibody–positive donors [HCV(+)Ds] has tripled in the United States. Although previous…”
Get full text

986 Simulation-Based Training of Minnesota Tube Placement for GI fellows: Utilization of a Mastery Learning Model for Low Volume Procedural Training by Kriss, Michael, Pigott, Courtney, Truesdale, Aimee E, Forman, Lisa M, Menard-Katcher, Paul, Burton, James R

Get full text

Prevalence of Primary Sclerosing Cholangitis in Black Patients: Results of a Multi-Center North American Consortium by Goldberg, David S, Yimam, Kidist, Eksteen, Bertus, Levy, Cynthia, Pratt, Dan, Schwarz, Kathleen B, Forman, Lisa M, Yu, Le, Rahimi, Robert, Assis, David, Bowlus, Christopher L

Get full text

Hepatitis C Genotype Influences Post-liver Transplant Outcomes by Campos-Varela, Isabel, Lai, Jennifer C, Verna, Elizabeth C, O’Leary, Jacqueline G, Todd Stravitz, R, Forman, Lisa M, Trotter, James F, Brown, Robert S, Terrault, Norah A

“…BACKGROUNDIn nontransplant patients with chronic hepatitis C virus (HCV), HCV genotype has been linked with a differential response to antiviral therapy, risk…”
Get full text

Statin-Induced Rhabdomyolysis Associated With Transjugular Intrahepatic Portosystemic Shunt Placement by Swei, Eric C., Brar, Anantnoor K., Rice, Jonathan D., Kim, Ike I., Knez, Virginia M., Doe, Christopher F., Forman, Lisa M.

“…Rhabdomyolysis is a known rare and potentially lethal complication of statin use. This toxic effect is potentiated by alterations in hepatic physiology in…”
Get full text

HBIg Discontinuation with Maintenance Oral Anti-viral Therapy and HBV Vaccination in Liver Transplant Recipients by Weber, Nicholas K, Forman, Lisa M, Trotter, James F

“…Background Hepatitis B (HBV) is an uncommon indication for liver transplantation in the US accounting for approximately 5% of cases. Recurrence prophylaxis is…”
Get full text

Long‐term management after liver transplantation: Primary care physician versus hepatologist by Heller, J. Christie, Prochazka, Allan V., Everson, Gregory T., Forman, Lisa M.

“…As long‐term survival after liver transplantation increases, metabolic complications are becoming increasingly prevalent. Given concerns about which group of…”
Get full text

Metabolic syndrome in liver transplantation: The elephant in the room by Forman, Lisa M.

Get full text

Mo1927 Incidence of Early Rejection Between Liver Transplant Recipients of Living Related Versus Unrelated Donor Organs by Fortune, Brett E, Sprague, David, Chascsa, David, Kirkland, Heather, Forman, Lisa M, Biggins, Scott W, Burton, James R

Get full text

Hepatic Artery Chemoembolization for Hepatocellular Carcinoma in Patients Listed for Liver Transplantation by Hayashi, Paul H., Ludkowski, Michael, Forman, Lisa M., Osgood, Michael, Johnson, Stephen, Kugelmas, Marcelo, Trotter, James F., Bak, Thomas, Wachs, Michael, Kam, Igal, Durham, Janette, Everson, Gregory T.

“…We retrospectively analyzed all listed patients having hepatic artery chemoembolization (HACE) for hepatocellular carcinoma (HCC) stage T2 or less. Outcomes…”
Get full text